169 related articles for article (PubMed ID: 37787838)
21. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
24. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis.
Zhang Q; Zhao YZ; Ma HH; Wang D; Cui L; Li WJ; Wei A; Wang CJ; Wang TY; Li ZG; Zhang R
Blood; 2022 Jun; 139(24):3493-3504. PubMed ID: 35344583
[TBL] [Abstract][Full Text] [Related]
25. Difficult Balance Between EBV Treatment and Posttransplant Immunosuppression: A Successful Transplant in a Child With Recurrent Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis.
Fałkowska A; Prądzyńska K; Drabko K
Transplant Proc; 2021; 53(6):2035-2039. PubMed ID: 33933286
[TBL] [Abstract][Full Text] [Related]
26. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.
Meng GQ; Wang JS; Wang YN; Wei N; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107606. PubMed ID: 33826999
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
28. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis.
Kim H; Mizuno K; Masuda K; Sakurai M; Ara T; Naito K; Uehara Y; Yamamoto G; Osada M; Machida S; Horio T; Fukushima K; Mori Y; Ichinohe T; Fukuda T; Atsuta Y; Kataoka K
Transplant Cell Ther; 2024 Apr; 30(4):419.e1-419.e12. PubMed ID: 38266963
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine/Melphalan 100 mg/m
Park HS; Lee JH; Lee JH; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1116-1121. PubMed ID: 30508593
[TBL] [Abstract][Full Text] [Related]
31. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.
Shao X; Xu Y; Xu X; Xu Y; Chen H; Hong M; Liu L
Isr Med Assoc J; 2018 Feb; 20(2):80-85. PubMed ID: 29431300
[TBL] [Abstract][Full Text] [Related]
33. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Li Z; Wang Y; Wang J; Zhang J; Wang Z
Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
[TBL] [Abstract][Full Text] [Related]
34. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
36. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
Matsuo Y; Iwanami K; Hiraoka E; Oda R
Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
[TBL] [Abstract][Full Text] [Related]
38. L-DEP regimen is effective as an initial therapy for adult EBV-HLH.
Chen L; Wang J; Wang Z
Ann Hematol; 2022 Nov; 101(11):2461-2470. PubMed ID: 36094533
[TBL] [Abstract][Full Text] [Related]
39. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
